Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco Solar ETF (TAN) vs GeneDx Holdings Corp (WGS) Price & Performance

Invesco Solar ETFTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Invesco Solar ETF vs GeneDx Holdings Corp — how do they compare? Invesco Solar ETF trades at $53.51, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Invesco Solar ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

TANWGS
Sector
Sector/ThematicTechnology
52-Week High
$73.95$167.51
52-Week Low
$36.07$34.51
Market Cap
$1.80B
Enterprise Value
$1.80B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco Solar ETF

TAN trades at $52.69, down 2.24% amid broad market weakness, with technical indicators signaling a bearish trend. The ETF faces headwinds from lower oil prices and a strong US dollar, though long-term growth prospects remain tied to rising electricity demand from data centers and AI. Recent news highlights both opportunities in the energy transition and risks from regulatory delays and geopolitical tensions affecting solar investments.

The outlook for TAN is cautious near-term due to technical deterioration and valuation concerns, but sustained demand for clean energy offers long-term potential. Key risks include policy uncertainty, competition from nuclear energy, and reliance on large-scale solar projects. Investors should weigh volatility against the structural shift toward renewable infrastructure.

GeneDx Holdings Corp

GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.

Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.

Returns comparison

Trailing returns across standard periods

About Invesco Solar ETF

TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.

Read more on TAN

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS